Covered recipient · General Payments record
JOHNNA B STAMPER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,473.71
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,319.20 | 57 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | $166.81 | 3 |
| Janssen Biotech, Inc. | $151.93 | 5 |
| ABBVIE INC. | $137.81 | 6 |
| Incyte Corporation | $95.83 | 4 |
| Daiichi Sankyo Inc. | $92.68 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $81.60 | 4 |
| Celgene Corporation | $57.14 | 3 |
| Genentech USA, Inc. | $56.05 | 3 |
| Acerta Pharma LLC | $49.90 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.48 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $48.36 | 2 |
| Astellas Pharma US Inc | $47.94 | 2 |
| TerSera Therapeutics LLC | $44.89 | 2 |
| Lilly USA, LLC | $40.82 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.94 | 1 |
| GlaxoSmithKline, LLC. | $32.48 | 2 |
| Blue Earth Diagnostics Limited | $27.86 | 1 |
| Ipsen Biopharmaceuticals, Inc | $27.39 | 1 |
| Genmab U.S., Inc. | $26.78 | 1 |
| Cumberland Pharmaceuticals, Inc. | $24.30 | 1 |
| Stemline Therapeutics Inc. | $21.51 | 1 |
| Immunocore Limited | $19.60 | 1 |
| ADC Therapeutics America, Inc. | $19.44 | 1 |
| Merck Sharp & Dohme Corporation | $17.78 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.44 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.26 | 1 |
| TAIHO ONCOLOGY, INC. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (58)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.